Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Title |
Grant Type |
Focus Area |
Country |
Application Due Date |
---|---|---|---|---|
Closing the HRRm Testing Gap in Prostate Cancer Patients
Release Date:
|
Quality Improvement | Oncology | Canada | |
Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial Infections
Release Date:
|
Education | Hospital | All | |
Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
Release Date:
Partner: Colorectal Cancer Canada (CCC)
|
Quality Improvement | Oncology | Canada | |
2024 Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
|
Quality Improvement | Rare Disease | All | |
Junior Investigator Global ATTR Cardiac Amyloidosis Research
Release Date:
|
Research | Rare Disease | Australia, Canada, France, Germany, Italy, Japan, Korea, Spain | |
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
|
Quality Improvement | Oncology | Spain | |
Quality Improvement Grants to Improve Identification and Management of Patients with ATTR Amyloidosis
Release Date:
|
Quality Improvement | Rare Disease | Spain | |
Release Date:
|
Education | Internal Medicine | USA | |
2024 IM US Headache Medicine Fellowship
Release Date:
|
Fellowship | Internal Medicine | USA | |
RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
Release Date:
|
Education | Vaccines | Japan | |
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
|
Fellowship | Rare Disease | USA |
Title |
Grant Type |
Focus Area |
Country |
Application Due Date |
---|---|---|---|---|
Pfizer and Global Bridges at Mayo Clinic: Treating Tobacco Dependence- Europe Program
Release Date:
|
||||
Implementation of MenB Vaccine Recommendations in Older Adolescents/Young Adults
Release Date:
|
||||
Rheumatology Fellowships
Release Date:
|
||||
Release Date:
|
||||
IPI and Pfizer: Device Challenge- System for Dosing and Dispensing Multiparticulate Formulations of Pediatric Drugs
Release Date:
|
||||
Pfizer and American Pain Society: Improving Chronic Pain Care
Release Date:
|
||||
Accelerating Improvements in Medication Optimization
Release Date:
|
||||
Haemophilia Early Arthropathy Detection with UltraSound (HEAD-US) Protocol for Routine Joint Assessment of Haemophilia Patients
Release Date:
|
||||
Improving Care of Patients with Atrial Fibrillation in Order to Reduce Stroke Risk
Release Date:
|
||||
IGLC_IHI_RFP Accelerating Improvements in Medication Optimization_Re-release
Release Date:
|
||||
Pfizer and Global Healthy Living Foundation: Rheumatoid Arthritis Shared Decision Making
Release Date:
|
||||
IBD Fellowship RFP 12212016
Release Date:
|